Bluejay Diagnostics
BJDX----
Bluejay Diagnostics (BJDX)
Bluejay Diagnostics, Inc. operates as a medical diagnostics company. It offers Symphony technology platform which consists of an analyzer and single-use protein...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Bluejay Diagnostics Analyst Rating
View MoreForecast & Rating
Aug 28, 2023Price forecast
$51200.004970773.79%
Forecast & Rating-
0analysts
News
- Global Report · 11 hours ago
Beyond the Mega-Caps: AI Patent Wars, Housing Slowdowns, and the Market's Messy Middle
- Tip Ranks · 1 day ago, 04:48 PM
Bluejay Diagnostics Completes Enrollment in SYMON-II Sepsis Study
- PUBT · 2 days ago, 12:30 PM
Bluejay Diagnostics initial beneficial ownership statement names Bank of America as 10% owner
- PUBT · Jul 21 at 05:32 AM
Bluejay Diagnostics announces SYMON-II sepsis study enrollment completion
- benzinga_article · Jul 20 at 07:05 AM
12 Health Care Stocks Moving In Monday's Pre-Market Session
- Global Report · Jul 19 at 04:12 AM
MedTech Restructuring Accelerates Against the Backdrop of Macro Capital Pressures
